Dr. Kiran Zahid* and Syed Muhammad Faheem Ahmad

Independent Researcher, United Kingdom

*Corresponding Author: Dr. Kiran Zahid, Independent Researcher, United Kingdom.

Received: January 23, 2026; Published: February 28, 2026

Abstract

Background: Alzheimer’s disease is a growing global health challenge, particularly in developing countries such as Pakistan. Older adults are the most affected, and effective curative treatments remain unavailable, highlighting the need to explore natural therapeutic options.

Methods: This study evaluated the antioxidant and phytochemical properties of wild strawberry leaf extracts and their potential protective effects against scopolamine-induced memory impairment in mice. Behavioural assessments and biochemical analyses were conducted to support the findings.

Results: Wild strawberry leaf extracts significantly improved memory performance and antioxidant status compared to the standard drug piracetam. GC–MS analysis identified bioactive compounds that may contribute to the observed neuroprotective effects.

Conclusion: These findings indicate that wild strawberry leaves may serve as a promising, natural, and cost-effective source for the prevention and management of Alzheimer’s disease.

Keywords: Malondialdehyde; Reduced Glutathione; Acetylcholinesterase; Scopolamine Hydrobromide; Alzheimer Disease

References

1. Agrawal S S and M Paridhavi. “Essentials of Crude Drugs”. Herbal Drug Technology, 1^st, Universities Press (2007): 583-87.
2. Ahmed T and A H Gilani. “Inhibitory Effect of Curcuminoids on Acetylcholinesterase Activity and Attenuation of Scopolamine Induced Amnesia May Explain Medicinal Use of Turmeric in Alzheimer’s Disease”. Pharmacology Biochemistry and Behavior 91 (2009): 554-559.
3. Ballard C G., et al. “Cholinesterases: Roles in the Brain during Health and Disease”. Current Alzheimer Research 2 (2005): 307-318.
4. Bombarely A., et al. “Generation and Analysis of ESTs from Strawberry (Fragaria × ananassa) Fruits and Evaluation of Their Utility in Genetic and Molecular Studies”. BMC Genomics 11 (2010): 503.
5. Bullock R. “New Drugs for Alzheimer’s Disease and Other Dementias”. The British Journal of Psychiatry 180 (2002): 135-139.
6. Chang Q and P E Gold. “Switching Memory Systems during Learning: Changes in Patterns of Brain Acetylcholine Release in the Hippocampus and Striatum in Rats”. Journal of Neuroscience 23 (2003): 3001-3005.
7. Cliffe S., et al. “Enzyme Assays for the Phenolic Content of Natural Juices”. Journal of Agricultural and Food Chemistry 42 (1994): 1824-1828.
8. Cummings JL. “Alzheimer’s Disease”. The New England Journal of Medicine 351 (2004): 56-67.
9. Dewanto V X., et al. “Thermal Processing Enhances the Nutritional Value of Tomatoes by Increasing Total Antioxidant Activity”. Journal of Agricultural and Food Chemistry 50 (2002): 3010-3014.
10. Fadda F., et al. “Hippocampal Acetylcholine Release Correlates with Spatial Learning Performance in Freely Moving Rats”. Neuroreport 11 (2000): 2265-2269.
11. Harbor J B. “Photochemical Methods: A Guide to Modern Techniques of Plant Analysis”. Chapman and Hall (1973).
12. Hasselmo M E. “The Role of Acetylcholine in Learning and Memory”. Current Opinion in Neurobiology 16 (2006): 710-715.
13. Heinrich M and H Lee Teoh. “Galanthamine from Snowdrop: The Development of a Modern Drug against Alzheimer’s Disease from Local Caucasian Knowledge”. Journal of Ethnopharmacology 92 (2004): 147-162.
14. Indumathi C., et al. “Estimation of Terpenoid Content and Its Antimicrobial Property in Enicostemma litorrale”. International Journal of ChemTech Research 6 (2014): 4264-4267.
15. Jawaid T., et al. “Evaluation of Cucurbita maxima Extract against Scopolamine Induced Amnesia in Rats: Implication of Tumour Necrosis Factor Alpha”. Zeitschrift fur Naturforschung C 69 (2014): 407-417.
16. Kang S Y., et al. “Decursin from Angelica gigas Mitigates Amnesia Induced by Scopolamine in Mice”. Neurobiology of Learning and Memory 79 (2003): 11-18.
17. Kanwal A., et al. “Anti Amnesic Activity of Vitex negundo in Scopolamine Induced Amnesia in Rats”. Scientific Research 1 (2010): 1.
18. Kubinova R., et al. “Anticholinesterase, Antioxidant Activity and Phytochemical Investigation into Aqueous Extracts from Five Species of Agrimonia Genus”. Natural Product Research 30 (2016): 1174-1177.
19. Lahiri D K., et al. “A Critical Analysis of New Molecular Targets and Strategies for Drug Developments in Alzheimer’s Disease”. Current Drug Targets 4 (2003): 97-112.
20. Lee S K., et al. “Evaluation of the Antioxidant Potential of Natural Products”. Combinatorial Chemistry and High Throughput Screening 1 (1998): 35-46.
21. Levesque R. “SPSS Programming and Data Management: A Guide for SPSS and SAS Users”. 4^th, SPSS Inc. (2007).
22. Neves JM., et al. “Ethnopharmacological Notes about Ancient Uses of Medicinal Plants in Trás os Montes (Northern Portugal)”. Journal of Ethnopharmacology 124 (2009): 270-283.
23. Power AE., et al. “Muscarinic Cholinergic Influences in Memory Consolidation”. Neurobiology of Learning and Memory 80 (2003): 178-193.
24. Salehi Surmaghi MH., et al. “Survey of Iranian Plants for Saponins, Alkaloids, Flavonoids and Tannins IV”. DARU: Journal of Pharmaceutical Sciences 2 (1992): 1-11.
25. Sun X L., et al. “Effect of Polygala tenuifolia Root Extract on Scopolamine Induced Impairment of Rat Spatial Cognition in an Eight Arm Radial Maze Task”. Biological and Pharmaceutical Bulletin 30 (2007): 1727-1731.
26. Terry A V., et al. “The Cholinergic Hypothesis of Age and Alzheimer’s Disease Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development”. Journal of Pharmacology and Experimental Therapeutics 306 (2003): 821-827.
27. Tota S., et al. “Improvement of Brain Energy Metabolism and Cholinergic Functions Contributes to the Beneficial Effects of Silibinin against Streptozotocin Induced Memory Impairment”. Behavioural Brain Research 221 (2011): 207-215.
28. Uddin M S., et al. “Neuroprotective Effect of Phyllanthus acidus L. on Learning and Memory Impairment in Scopolamine Induced Animal Model of Dementia and Oxidative Stress”. Advances in Alzheimer Disease 5 (2016): 53.
29. Venigalla M., et al. “Novel Promising Therapeutics against Chronic Neuroinflammation and Neurodegeneration in Alzheimer's Disease”. Neurochemistry International 95 (2016): 63-74.
30. Wang Q., et al. “Comparison of Ginsenosides Rg1 and Rb1 for Their Effects on Improving Scopolamine Induced Learning and Memory Impairment in Mice”. Phytotherapy Research 24 (2010): 1748-1754.
31. Wyk B and M Wink. “Medicinal Plants of the World”. MedPharm (2007).
32. Yang J H., et al. “Ginsenoside Rh2 Ameliorates Scopolamine Induced Learning Deficit in Mice”. Biological and Pharmaceutical Bulletin 32 (2009): 1710-1715.
33. Thomas E T P A., et al. “GC MS Analysis of Phytochemical Compounds Present in the Rhizomes of Nervilia aragoana Gaud”. Asian Journal of Pharmaceutical and Clinical Research 6 (2013): 68-74.
34. Sosa AL., et al. “Prevalence, Distribution, and Impact of Mild Cognitive Impairment in Latin America, China, and India: A 10/66 Population Based Study”. PLoS Medicine 9 (2012): e1001170.
35. Polidori M C and R J Schulz. “Nutritional Contributions to Dementia Prevention: Main Issues on Antioxidant Micronutrients”. Genes and Nutrition 9 (2014): 1-11.
36. Larson EB., et al. “New Insights into the Dementia Epidemic”. New England Journal of Medicine 369 (2013): 2275-2277.

Citation

Citation: Krishna NS and SG Praveen. “Anti-Alzheimer Activity of Fragaria vesca L. Leaf extract in Scopolamine Induced Amnesia in Mus Musculus". Acta Scientific Neurology 9.3 (2026): 25-34.

Copyright

Copyright: ©2026 Krishna NS and SG Praveen. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.